Articles
o xygen supplementation is one of the most common therapeutic interventions in resuscitation and neonatal intensive care of term and preterm infants (1) . However, both hypoxia and hyperoxia must be avoided because of their detrimental effects on morbidity and mortality in these children. While hypoxia may lead to direct and indirect cellular damage, hyperoxia has been associated with oxygen toxicity, oxidative stress (2) , and chronic diseases of preterm infants such as bronchopulmonary dysplasia (3) and retinopathy of prematurity (4) .
Increase in oxygenation after birth is a gradual process (5) . Measurement of oxygen saturation (SpO 2 ) by pulse oximetry in the delivery room is feasible in newborn resuscitation (6) and in preterm infants within the first minutes of life (7) . SpO 2 reference values of preterm infants increase within the first 10 min of life (5) . This has led to SpO 2 target values incorporated in the current European Resuscitation Council guidelines on resuscitation of newborns (8) . In order to avoid hyperoxia, current recommendations advise resuscitation of preterm infants with a mixture of air and oxygen, and to use fraction of inspired oxygen (FiO 2 ) between 0.21 and 0.30 (9) . FiO 2 should subsequently be titrated according to SpO 2 (10, 11) . General use of pulse oximetry has been shown to extensively reduce O 2 -derived toxicity in preterm infants (12) . However, keeping SpO 2 manually within changing saturation limits during a hectic period of resuscitation is a difficult task. Large deviations from SpO 2 targets during resuscitation of preterm infants have been observed in clinical studies (13) .
These deviations have also been described during routine NICU care, where SpO 2 target ranges are met during 50% of the time (14, 15) . Meeting SpO 2 targets affects morbidity and mortality, depending on the target range chosen (16) (17) (18) . Beside overall SpO 2 targets, variability of oxygenation influences outcome of preterm infants (4, 19, 20) . A promising solution to optimize oxygen therapy is the employment of an automatic "closed loop" system for regulation of FiO 2 based on SpO 2 . Several clinical trials with different devices have proven feasibility of automated closed loop FiO 2 control in the NICU for various modes of ventilation, mixed populations, and by using different algorithms (14, (21) (22) (23) (24) (25) (26) . In addition, an overall reduction of manual interventions during automated control was found in these studies, indicating facilitation of caretakers and nursing staff in clinical routine (27, 28) . However, at least one study raised concerns about safety, as time within target range was accompanied by an increase in time spent below saturation target range (25) .
The delivery of oxygen is also crucial in the delivery room setting where automated FiO 2 control has not yet been tested (28) . We therefore hypothesized that an algorithm developed for automated FiO 2 control during mechanical ventilation was feasible in the delivery room setting with rapidly changing physiology of fetal transition to extra-uterine life and during surfactant replacement therapy. We further hypothesized that fully automated FiO 2 control conducted by this algorithm would keep SpO 2 within a predefined target range as good as a dedicated caretaker during stable ventilation conditions. We tested our hypotheses in an established lamb model of preterm respiratory distress syndrome.
RESULTS

Animal Characteristics
Preterm lambs did not vary significantly in baseline characteristics and ventilation parameters in both the resuscitation part and the stable ventilation part of the study ( Table 1) . From 22 animals, 19 animals could be included for analysis of the resuscitation period. 2 animals were excluded because the control software was unintentionally activated other than intended in the protocol, and one animal was excluded because of sensor malfunction. In all animals included, time until first SpO 2 measurement was about 2 min (median 106 s, interquartile range (IQR) (80-148 s)) and time until pulse readout of the pulse oximeter correlated to the heart rate was 3 min on average (median 181 s, IQR (129-271 s)). Fifteen animals underwent automated FiO 2 control during resuscitation, from which 9 started with a FiO 2 of 0.3 and 6 started with a FiO 2 of 0.6. In four animals FiO 2 was controlled manually (starting from FiO 2 0.3 in 3 and from FiO 2 0.6 in 1 animal).
Resuscitation
SpO 2 target during resuscitation was defined as 25th and 75th percentile over time for both groups (Figure 1a) . Relative time within target range did not differ significantly within groups ( Table 2) . However, we observed significantly less time spent above the target range in the automated group, while time below the target range was similar ( Table 2) .
Average time until first FiO 2 adjustment was below 3 min in both the automated and the manual group (median 160 s, IQR (134-208 s) vs. 149 s (81-1698 s), P = 0.317). The average number of adjustments during resuscitation was similar in both groups (median 27, IQR (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) vs. 28 (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) ; P = 0.796). (Figure 1b) , however the oxygen need was highly variable in both the automated (IQR (0.52-0.98)) and the manual group (IQR (0.37-0.72)).
Automated FiO 2 Control During Stabilization and Surfactant Replacement Therapy
Nine animals received surfactant replacement therapy in the stabilization period during automated FiO 2 control. After surfactant replacement, FiO 2 was decreased from 0.97 (IQR (0.86-0.99)) to 0.46 (0.35-0.56) in 14 (10-16) steps (Figure 2b) . The maximum number of steps the algorithm could make due to timeout restrictions of 30 s between steps was 20. Average time until the last FiO 2 step down after surfactant replacement was 623 s (IQR 421-807 s).
In the 10 min after surfactant administration SpO 2 was subsequently kept close to target ranges, but was within the target range 44% of the time and above the range 54% (Figure 2a) . Average time until SpO 2 was again within target range after surfactant replacement was 576 s (387-650 s). SpO 2 , however, reached 100% in only 9% of the time. Articles Hütten et al.
Stable Ventilation
Animals were stabilized within the first half hour of life (median 33:11 min:sec, IQR (30:01-39:47 min:sec)). During the subsequent stable ventilation phase, time spend within the target range was significantly higher when the automated controller was used (93.2% (80.6-98.9%) vs. 84.0% (63.8-89.4%), P < 0.05, Figure 3a) , and time outside the target range, depicted as area under the curve (SpO 2 *sec per hour) was significantly lower (Figure 3a) . The number of episodes outside the target range per hour was also significantly lower in the automated group (Table 3) . When comparing hypoxic and hyperoxic episodes, animals ventilated with automated control had significantly less episodes below the lower target saturation of 90% and showed a trend toward less hyperoxic episodes per hour (P = 0.065, Table 3 ). We observed only a small number of short hypoxic (<85%) and severe hypoxic (<75%) episodes in our model, and number of these episodes did not differ between groups. This was also reflected in the low average deviation of saturation from the median target saturation in both groups ( Table 3) . The duration of hyperoxic, hypoxic and severe hypoxic episodes did no differ significantly between groups.
Compared to manual control, the number of FiO 2 adjustments per hour was 2.3 times higher in the automated group, although this difference was not significant (median 13.0, IQR (3.0-16.4) vs. 5.7 (2.3-9.8), P = 0.243). Applied FiO 2 did not differ significantly between groups, and we observed a heterogeneous need for oxygen within the groups (Figure 3b) . Animals in the manual group were outside target range longer with higher oxygen need, however correlation between time outside target range and average FiO 2 was not significant (R 2 linear = 0.614, P = 0.889). In the automated group, average FiO 2 and time outside target range did not correlate (R 2 linear = 0.229, P = 0.136).
DISCUSSION
We tested in our study if fully automated FiO 2 control without manual interventions was feasible to keep preterm lambs within a predefined SpO 2 target range under both rapidly changing conditions in a delivery room setting and under stable volume guarantee ventilation. Tailoring oxygen supplementation to the needs of preterm infants in the first minutes of life is difficult because of the gradual increase of oxygenation (5). In our study, time within target range with both manual and automated FiO 2 control resembled clinical data obtained in the delivery room (13) .
Our data indicated that automated FiO 2 control avoided hyperoxia during resuscitation. This might have resulted from the algorithm following the target ranges in a stricter way than the human controller, although the number of adjustments and time until first FiO 2 adjustment did not differ between groups. However, we did not see significantly more time within target range in automated FiO 2 control during resuscitation. A possible explanation is that the caretaker providing manual FiO 2 adjustments was able to see the changing SpO 2 target ranges depicted as Dawson's curve during resuscitation Data is given as median and (IQR). *P < 0.05 compared to manual.
Articles and therefore had more information about saturation trends than in a standard delivery room. This could have facilitated the decision for which FiO 2 to provide, and made it easier to achieve saturations within the limits than during routine clinical resuscitation where SpO 2 is presented only by pulse oximeter readout. However, we cannot rule out that the manual adjustments were based on additional clinical parameters such as heart rate, although heart rate increased adequately in both groups. Automated FiO 2 control might be further improved by choosing a narrowed target range. By basing the target range on Dawson's curve, the predefined range was broader during resuscitation than during subsequent ventilation. Closed loop FiO 2 control has already been shown to maintain functionality in a setting of narrowed target ranges in the NICU (29) . Furthermore, automated FiO 2 control might be improved by allowing the algorithm to change FiO 2 more frequently, although the limitation of at least 30 s between two steps resembled clinical recommendations (10) . Avoidance of oxygen overexposure is a major concern for implementing automated control in the delivery room (28) . In our study, animals resuscitated with an initial FiO 2 of 0.3 showed less SpO 2 above target range than animals initially resuscitated with FiO 2 0.6, although FiO 2 had to be increased during resuscitation in the first group. The starting FiO 2 had an effect until about 5 min after birth. This observation is in accordance to a previous study where initial FiO 2 of 0.3 or 0.65 had a significant effect on the FiO 2 during the first 6 min of life (30) . This data supports previous findings that resuscitation with initially low FiO 2 might be beneficial for preterm infants (9) . Automated FiO 2 control was also feasible directly after surfactant replacement therapy. The automated controller showed immediate and adequate reaction on the altered needs for supplemental oxygen. In this scenario, a caretaker might have the advantage from knowing what to expect from the applied treatment. However, the small number of animals receiving surfactant during the study did not allow us a direct comparison between automated and manual control after surfactant replacement therapy.
During stable ventilation, animals receiving automated FiO 2 control spent significantly more time within the predefined target range. This advanced performance of the controller was striking, as manual control was performed in a 1-on-1 setting by a person without other tasks than ventilation control during the experiment. This dedicated FiO 2 control, which is different from the clinical situation, improved time within target range compared to routine control in a previous study (23) . In a clinical setting, meeting SpO 2 target ranges depends-among others-on patient-caretaker ratio (31) . Most closed loop studies compared automated to routine clinical care (14, 21, (24) (25) (26) , only one study could show a significant improvement comparing closed loop to dedicated manual control (22) . In addition, in our study, alarm range was equal to target range, which created an ideal setting for dedicated manual control as caregivers are more effective in keeping SpO 2 within alarm limits then within target limits in preterm infants (32) . Interestingly, our data suggest that keeping animals manually within the limits was more difficult with high oxygen need, while individual oxygen need did not influence the performance of the automated control.
We therefore conclude that automated FiO 2 control is applicable both during rapidly changing physiologic conditions and during stable ventilation. Automated FiO 2 control has therefore the potential to facilitate delivery room management during resuscitation. On the NICU, automated FiO 2 control reduced the need for manual interventions during automated control by 33-90% (23) (24) (25) . Only one study reported no manual interventions during automated control (22) , however the overall time within target range for both manual and automated control was lower and the target range was wider compared to our study. The potential of acting autonomously for at least a certain time is a prerequisite of safe use of automated FiO 2 control in this vulnerable patient population.
Nevertheless, automated control cannot outrun clinical experience, as therapeutic interventions in the delivery room have to be adapted to a multitude of parameters (33) . Early SpO 2 is related not only to FiO 2 , but also to factors like adequate functional residual capacity (34) and perinatal procedures like delayed cord clamping (35) . In addition, rising need for oxygen can be a symptom of a pathological condition such as pneumothorax or of a ventilation-related complication, e.g., tube dislocation. Automated control may mask these changes, at least for a short period of time. Therefore, adequate feedback about automated intervention to the caretaker must be ensured. Additional alarms for parameters like tidal volume (TVe) should be routinely implemented.
Our model is limited by the fact that animals were mildly sedated for mechanical ventilation, partially preventing spontaneous breathing. Hypoventilation after episodes of active breathing during mechanical ventilation has been previously described as important contributor to desaturations Step size adjuster Safety check in ventilated preterm children (36) . Automated FiO 2 control might be ineffective in prevention of hypoxic spells (27) . However, our data suggest that automated control prevented episodes below target and might therefore have an effect on these episodes, as hypoxic spells have been associated with lower average SpO 2 levels (37). This highlights the need for additional studies investigating the influence of parameters defining the automated controller. In summary, to the best of our knowledge, this is the first study where we demonstrate that fully automated FiO 2 control is feasible during neonatal resuscitation in a near-clinical preterm delivery room setting, and that automated control prevents hyperoxia. We speculate that in a clinical scenario where not only SpO 2 but also clinical evaluation of the patient influence oxygen therapy, the combination of automated and manual control might even imply better results. However, this question may best be addressed in a clinical trial. In parallel, translational trials will help to improve closed-loop equipment.
METHODS
Experimental Setup
An infant ventilator (Fabian HFO, Acutronic, Hirzel, Switzerland) was prepared for digital control of the FiO 2 . SpO 2 measurement was obtained via a Masimo pulse oximeter (Radical 7, Masimo, Irvine, CA). Both devices were linked to a laptop computer (ThinkPad T500, Lenovo Pte., Singapore, with Windows 7, Microsoft, Redmond, WA), containing control software with a user interface showing SpO 2 , FiO 2 , pulse, and SpO 2 target ranges over time (as presented by Goos et al. on the 4th Congress of the European Academy of Pediatric Societies 2012). The algorithm used was a rule based control scheme that used both the current SpO 2 together with the trend in the SpO 2 measurement (Figure 4) . The trend was used to fine tune the FiO 2 step size by recognizing larger and quicker changes. A prediction based on the trend was used to limit under-and overshoot. A number of safety checks were performed before an automated FiO 2 adjustment could be made, i.e. check for proper ventilation (TVe and percentage of leak within acceptable limits), reliable connections between all devices and an assessment of the correctness of all measured parameters. After each adjustment, a 30 s time out followed to allow the effect of the adjustment to be observed.
Animal Study
The lamb model of neonatal respiratory distress syndrome allowed us a translational approach due to its physiologic similarities to lung development in humans (38, 39) . Furthermore, anatomy and body size allowed us the use of the original equipment used in the neonatal intensive care units. The study design and the experimental protocol were in line with the institutional guidelines for animal experiments and were approved by the institutional Animal Ethics Research Committee, Maastricht University, The Netherlands.
One day before cesarean section, 22 date-mated ewes received an intramuscular injection with betamethasone (12 mg, Celestone Chronodose, Schering-Plough, North Ryde, New South Wales, Australia) to induce fetal lung maturation (40) . Before delivery, lambs were randomly assigned to four different treatment groups for resuscitation and independently for two different treatment groups for subsequent stable ventilation. This setup allowed us to separately analyze the algorithm during rapidly changing and stable conditions.
Resuscitation
Lambs were operatively delivered prematurely at a gestational age of 128-132 d (term ~150 d) via a modified EXIT procedure, equipped with umbilical artery and vein catheters and intubated orally with a cuffed tube (41) . The arterial catheter was used to monitor heart rate and blood pressure, and to frequently obtain blood for blood gas analysis. After cord clamping, lambs were weighed, sedated, and transferred to an infant radiator bed (IW930 Series CosyCot Infant Warmer, Fisher & Paykel Healthcare, Auckland, New Zealand). An adhesive pulse oximeter sensor (M-LNCS Neo, MasimoSET, Masimo, Irvine, CA) was placed around the tongue and subsequently connected to the pulse oximeter. Resuscitation in the first 15 min was standardized to the greatest possible extend. This was achieved by connecting lambs to an infant ventilator set to volume-controlled mechanical ventilation (volume guarantee 6-7 ml/kg, max. PIP 45 cmH 2 O, frequency 50/min). FiO 2 at start of resuscitation was randomized to either 0.3 or 0.6. FiO 2 was adjusted to keep the lamb within the 25th and 75th percentile of saturation in preterm infants according to Dawson (5) for the first 10 min and subsequently between 90 and 95%. In all experiments, FiO 2 was either controlled by the algorithm alone, without manual interventions allowed, or by a caretaker. This person was solely dedicated to adjusting FiO 2 , while resuscitation was performed by others. FiO 2 adjustment was performed by experienced animal researchers and medical doctors or last year students with experience in neonatology, who were not limited regarding frequency and size of FiO2 changes. Outcome parameters for the resuscitation part were time within, above and below target range, number of events outside the target range, and total number of FiO 2 adjustments.
Stabilization and Surfactant Replacement Therapy
Resuscitation was followed by a short stabilization period. Animals which needed a fraction of inspired oxygen (FiO 2 ) above 0.8 at any time during resuscitation or stabilization were eligible to receive surfactant replacement therapy with Poractant alfa (Curosurf, 100 mg/kg body weight, a gift of Chiesi Pharmaceuticals, Pari, Italy). Lambs were considered to be stabilized after 30 min, or if they received surfactant, 15 min after surfactant replacement therapy. We recorded SpO 2 and FiO 2 before and after surfactant replacement therapy.
Stable Ventilation
After stabilization, stabilized lambs were mechanically ventilated with either automated or manual FiO 2 control for 3 h. Automated FiO 2 control was performed without additional manual interventions. In the manual group, caretaker-lamb ratio was 1:1. Arterial blood gas analysis was obtained every 30 min and respiratory settings were adjusted to keep P a CO 2 between 45 and 65 mmHg. Saturation target range was 90-95% according to current consensus guidelines from European neonatologists (42) , and the alarm range was set accordingly. Outcome parameters were time within and outside SpO 2 target range (90-95%), number and duration of episodes of hyperoxia (SpO 2 > 95%), hypoxia (< 85%) and severe hypoxia (< 75%), average variation from median target saturation and total number of FiO 2 adjustments. For analysis, we excluded times when (i) animals showed saturation above the high target without a need for supplemental oxygen or when (ii) SpO 2 was below the low target despite a FiO 2 of 1.0. This was done because during these episodes, FiO 2 control alone was not capable of keeping oxygen targets within the predefined limits.
Statistics
Normally distributed data are expressed as mean and SD, non-normally-distributed data are expressed as median and IQR. Statistical analysis was performed using Student's t-test for normally distributed data and Mann-Whitney test for non-normally distributed data, using IBM SPSS version 20 (IBM, Armink, NY). Graphs were drawn with Microsoft Excel 2010 and GraphPad Prism v5.0 (GraphPad Software, San Diego, CA). Significance was accepted at p<0.05.
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